60 Participants Needed

fMRI-Neurofeedback for PTSD

AA
JM
Overseen ByJonathan M Lieberman, BSc
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help people with PTSD, a condition that can develop after experiencing trauma, learn to control specific brain activities contributing to their symptoms. Participants will use real-time MRI biofeedback, a technique providing feedback on brain activity, to regulate brain areas like the amygdala and the posterior cingulate cortex, which are linked to PTSD. The study will compare the effects of this neurofeedback with sham feedback to determine its effectiveness in reducing PTSD symptoms. Individuals diagnosed with PTSD and comfortable using electronic devices might be a good fit for this trial. As an unphased trial, this study offers participants the chance to contribute to innovative research that could lead to new PTSD treatments.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you are using chronic opioid analgesics or have active substance use issues, you may be excluded from participating.

What prior data suggests that this fMRI neurofeedback technique is safe for PTSD patients?

Research has shown that fMRI neurofeedback is generally well-tolerated by people with PTSD. Participants in studies learned to control their brain activity through real-time feedback without major side effects. No one in these studies reported serious negative effects from the treatment, suggesting it is safe for use.

The treatment uses MRI technology to provide live feedback on brain activity, helping patients learn to change how their brains respond to stress. Although researchers are still studying the treatment, earlier studies have found no major safety issues. This is encouraging for those considering joining a clinical trial.12345

Why are researchers excited about this trial?

Researchers are excited about using MRI neurofeedback for PTSD because it offers a unique, non-invasive way to directly influence brain activity. Unlike traditional treatments like therapy or medication, which often take time to show effects, MRI neurofeedback allows participants to receive real-time feedback on their brain activity, potentially leading to faster changes in brain patterns associated with PTSD. Specifically, this approach targets brain regions like the amygdala and the posterior cingulate cortex, which are crucial in processing emotions and self-reflection, respectively. By directly interacting with these brain areas, MRI neurofeedback could offer a new avenue for managing PTSD symptoms more effectively.

What evidence suggests that fMRI Neurofeedback might be an effective treatment for PTSD?

Research has shown that neurofeedback, a therapy where individuals learn to control their brain activity, can help reduce PTSD symptoms. Studies have found that this treatment offers moderate benefits for PTSD and can also improve related depression and anxiety. In this trial, participants will receive real-time fMRI neurofeedback, which uses brain scans to provide feedback, focusing on areas of the brain important for emotion and memory, such as the amygdala and the posterior cingulate cortex (PCC). Some participants will receive a sham neurofeedback signal as a control. Multiple studies support that this approach can lead to meaningful improvements, especially over time.24678

Are You a Good Fit for This Trial?

This trial is for English-speaking adults aged 18-65 with PTSD, comfortable with tech like laptops and smartphones. Participants must have a PTSD diagnosis as per DSM-5 criteria but can also have depression or anxiety disorders. Exclusions include pregnancy, serious illnesses, MRI contraindications (like metal implants), neurological issues, untreated major illnesses, substance abuse in the last three months, claustrophobia, prior neurofeedback therapy or brain stimulation treatments.

Inclusion Criteria

Fluent English speaker
Able to provide written informed consent
Comfortable using electronic devices (i.e., laptop, tablet, smartphone, etc.)
See 1 more

Exclusion Criteria

Meeting criteria for substance use disorder in the past three months
I am currently in therapy specifically for trauma.
History of claustrophobia
See 11 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Clinical Assessment

Baseline clinical assessments including MINI and CAPS-5 to establish mental health disorder diagnoses and PTSD symptom severity

1 week
1 visit (in-person)

Self-report Assessments

Participants complete a battery of self-report questionnaires via REDCap

1 week

rt-fMRI Neurofeedback Sessions

3 rt-fMRI neurofeedback sessions over 3 weeks, including pre-session RSDI, localization scan, anatomical scan, resting-state scan, and task runs

3 weeks
3 visits (in-person)

Actigraphy Monitoring

Participants wear actigraphy devices to monitor biological rhythms and physical activity

7 weeks

Follow-up

Participants are monitored for changes in PTSD symptoms, interoceptive awareness, emotion regulation, and other measures at a 1-month follow-up

4 weeks
1 visit (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • MRI Biofeedback
  • Sham-MRI Biofeedback
Trial Overview The study tests if multiple sessions of real-time fMRI neurofeedback can help PTSD patients control abnormal brain activity linked to their condition. It compares two targets for feedback: the amygdala and posterior cingulate cortex against sham controls to see which affects symptoms and neural connectivity better.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Sham-controlExperimental Treatment1 Intervention
Group II: Posterior cingulate cortex (PCC)Experimental Treatment1 Intervention
Group III: AmygdalaExperimental Treatment1 Intervention

MRI Biofeedback is already approved in United States for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as fMRI Neurofeedback for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Andrew Nicholson

Lead Sponsor

Trials
1
Recruited
60+

McMaster University

Collaborator

Trials
936
Recruited
2,630,000+

Western University

Collaborator

Trials
31
Recruited
129,000+

University of Ottawa

Collaborator

Trials
231
Recruited
267,000+

Published Research Related to This Trial

This study investigates the use of real-time functional magnetic resonance imaging (rtfMRI) neurofeedback training (NFT) in alcohol-dependent patients to help them manage cravings and prevent relapse, with participants receiving six NFT sessions over four months.
The primary goal is to determine if NFT can effectively teach participants to regulate their brain responses to alcohol-related stimuli, potentially leading to reduced alcohol consumption, as measured by various metrics such as days abstinent and drinking frequency.
Neurofeedback training for alcohol dependence versus treatment as usual: study protocol for a randomized controlled trial.Cox, WM., Subramanian, L., Linden, DE., et al.[2022]
Real-time functional magnetic resonance imaging (fMRI) allows individuals to gain control over their own brain activity through neurofeedback, which could be beneficial for self-regulation.
This technique has potential therapeutic implications for patients with neuropsychiatric disorders, although the review also discusses the technical requirements and limitations of its application.
Making sense of real-time functional magnetic resonance imaging (rtfMRI) and rtfMRI neurofeedback.Brรผhl, AB.[2018]
Real-time functional magnetic resonance imaging neurofeedback (rtfMRI-NF) shows a medium-sized effect on neural activity during training and a large effect on neural activity after training, indicating its potential to influence brain function in psychiatric disorders.
Behavioral outcomes from rtfMRI-NF, such as symptom reduction, show a small effect size, suggesting that while rtfMRI-NF can impact brain activity, its effects on behavior may be less pronounced and require further investigation.
The efficacy of real-time functional magnetic resonance imaging neurofeedback for psychiatric illness: A meta-analysis of brain and behavioral outcomes.Dudek, E., Dodell-Feder, D.[2022]

Citations

Neurofeedback for post-traumatic stress disorder: systematic ...Neurofeedback (NFB) was found to have moderate beneficial effects on PTSD symptoms, and positive effects on secondary outcomes such as depression and anxiety, ...
The efficacy of real-time functional magnetic resonance ...We present the first meta-analysis of rtfMRI-NF for psychiatric disorders, evaluating its impact on brain and behavioral outcomes.
Systematic review and meta-analysis of neurofeedback ...Based on newer published studies and the outcomes measured, NF has demonstrated a clinically meaningful effect size, with an increased effect size at follow-up.
Neurofeedback of Amygdala Activity for Post-traumatic ...The primary purpose of this study is to investigate the efficacy of neurofeedback (NF) of real-time functional magnetic resonance imaging (rt-fMRI) data of the ...
A meta-analysis of brain and behavioral outcomes - PMCWe present the first meta-analysis of rtfMRI-NF for psychiatric disorders, evaluating its impact on brain and behavioral outcomes.
Current Status of Neurofeedback for Post-traumatic Stress ...With neurofeedback, patients can unconsciously self-regulate brain activity via real-time monitoring and feedback of the EEG or fMRI signals.
Real-Time fMRI Neurofeedback with PTSDHere, we describe a novel neurofeedback (NF) intervention using real-time functional magnetic resonance imaging for treating and studying PTSD. The ...
fMRI-Neurofeedback for PTSDResearch shows that real-time fMRI neurofeedback can help people with PTSD, like war veterans, learn to control brain activity related to stress, leading to ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity